In a defeat for one of the biggest US drug makers the US Trade Representative has decided not to add Canada to its Priority Watch list of countries that fail to sufficiently protect and enforce patent rightsÂ The agencys decision comes despite a recent lobbying effort in Washington by Eli Lilly  Co